| Amgen (Europe) GmbH |
| www.amgen.com |
| ||||
| [email protected] | |||||
| Tel: +41 (0)413690300 | |||||
Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients. | |||||